Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q1 2026 Earnings Call Transcript
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q1 2026 Earnings Call Transcript May 12, 2026Atea Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.57, expectations were $-0.6.

